NeoClone Overview

  • Founded
  • 1999
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $300K
Latest Deal Amount
  • Investors
  • 3

NeoClone General Information

Description

Developer of monoclonal antibodies designed to assist in biological research and also the biotechnology markets. The company's antibodies use proprietary technology for selecting, enriching, and amplifying murine or human antigen-specific antibody-producing cells and stimulate class-switched, affinity matured Ig -secretors to proliferate, which increases the number of antigen-specific Ig-secreting cells relative to non-specific Ig-secreting cells, enabling clients to get quality antibodies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1202 Ann Street
  • Madison, WI 53713
  • United States
+1 (608) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoClone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 12-Jan-2013 $300K 00.00 00.00 Completed Generating Revenue
3. Grant 01-Sep-2012 00.000 00.00 Completed Generating Revenue
2. Later Stage VC 01-Mar-2011 $750K $1.3M Completed Generating Revenue
1. Debt - General $550K $550K Completed Startup
To view NeoClone’s complete valuation and funding history, request access »

NeoClone Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of monoclonal antibodies designed to assist in biological research and also the biotechnology markets. The com
Biotechnology
Madison, WI
5 As of 2021
00.00
0.00 0000-00-00
0000000000 0 00.00

000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000 000000000
Lebanon, NH
000 As of 0000
00000
000000 - 000 00000

00000000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000 000000000
San Diego, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeoClone Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adimab Venture Capital-Backed Lebanon, NH 000 00000 000000 - 000 00000
00000000 000000000 Venture Capital-Backed San Diego, CA 000 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000000 000000000 Corporation Limerick, PA 0 0000000000
0000000000 Formerly VC-backed San Diego, CA 00 00000 000000 - 000 00000
You’re viewing 5 of 23 competitors. Get the full list »

NeoClone Executive Team (4)

Name Title Board Seat Contact Info
Deven McGlenn Co-Founder, Chief Executive Officer & Board Member
You’re viewing 1 of 4 executive team members. Get the full list »

NeoClone Board Members (6)

Name Representing Role Since
Deven McGlenn NeoClone Co-Founder, Chief Executive Officer & Board Member 000 0000
Meru Thakur NeoClone Board Member 000 0000
Mindy Brooks Ph.D Self Board Member 000 0000
Richard Burgess Ph.D Self Board Member & Scientific Advisor 000 0000
Richard Leazer Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

NeoClone Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeoClone Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Wisconsin Investment Partners Venture Capital Minority 000 0000 000000 0
To view NeoClone’s complete investors history, request access »